First Experience Addressing the Prognostic Utility of Novel Urinary Biomarkers in Patients with COVID-19
Keyword(s):
Abstract Urine 11-dehydro-thromboxane B2 (u11-dh-TxB2), 8-hydroxy-2'-deoxyguanosine, and liver-type fatty acid binding protein levels (L-FABP) at the time of hospitalization were higher in COVID-19 patients with adverse events versus without events. Higher u11-dh-TxB2 and L-FABP levels were associated with longer hospitalization, more thrombotic events, and greater mortality, providing evidence for potential utility as early prognostic biomarkers for COVID-19.
2018 ◽
Vol 22
(1)
◽
pp. 1-6
2016 ◽
Vol 40
(11)
◽
pp. 1649-1654
◽
2018 ◽
Vol 32
(12)
◽
pp. 1100-1104
◽
2017 ◽
Vol 33
(2)
◽
pp. 309-315
◽